{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:27:13Z","timestamp":1768343233497,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T00:00:00Z","timestamp":1432771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s12035-015-9218-y","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T04:10:03Z","timestamp":1432699803000},"page":"3136-3145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Factors Responsible for Plasma \u03b2-Amyloid Accumulation in Chronic Kidney Disease"],"prefix":"10.1007","volume":"53","author":[{"given":"Janine","family":"Gronewold","sequence":"first","affiliation":[]},{"given":"Hans-Wolfgang","family":"Klafki","sequence":"additional","affiliation":[]},{"given":"Enrico","family":"Baldelli","sequence":"additional","affiliation":[]},{"given":"Britta","family":"Kaltwasser","sequence":"additional","affiliation":[]},{"given":"Ulla K.","family":"Seidel","sequence":"additional","affiliation":[]},{"given":"Olga","family":"Todica","sequence":"additional","affiliation":[]},{"given":"Michaela","family":"Volsek","sequence":"additional","affiliation":[]},{"given":"Ute","family":"Hau\u00dfmann","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[]},{"given":"Andreas","family":"Kribben","sequence":"additional","affiliation":[]},{"given":"Heike","family":"Bruck","sequence":"additional","affiliation":[]},{"given":"Dirk M.","family":"Hermann","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,5,28]]},"reference":[{"issue":"4","key":"9218_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","volume":"28","author":"BV Zlokovic","year":"2005","unstructured":"Zlokovic BV (2005) Neurovascular mechanisms of Alzheimer\u2019s neurodegeneration. Trends Neurosci 28(4):202\u2013208. doi:\n10.1016\/j.tins.2005.02.001","journal-title":"Trends Neurosci"},{"issue":"5","key":"9218_CR2","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","volume":"115","author":"BV Zlokovic","year":"2010","unstructured":"Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA (2010) Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer\u2019s amyloid beta-peptide elimination from the brain. J Neurochem 115(5):1077\u20131089. doi:\n10.1111\/j.1471-4159.2010.07002.x","journal-title":"J Neurochem"},{"issue":"9415","key":"9218_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/s0140-6736(04)15900-x","volume":"363","author":"I Casserly","year":"2004","unstructured":"Casserly I, Topol EJ (2004) Convergence of atherosclerosis and Alzheimer\u2019s disease: inflammation, cholesterol, and misfolded proteins. Lancet 363(9415):1139\u20131146. doi:\n10.1016\/s0140-6736(04)15900-x","journal-title":"Lancet"},{"issue":"3","key":"9218_CR4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/s1474-4422(08)70040-1","volume":"7","author":"P Moorhouse","year":"2008","unstructured":"Moorhouse P, Rockwood K (2008) Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 7(3):246\u2013255. doi:\n10.1016\/s1474-4422(08)70040-1","journal-title":"Lancet Neurol"},{"issue":"12","key":"9218_CR5","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1038\/nm.3734","volume":"20","author":"FC Maier","year":"2014","unstructured":"Maier FC, Wehrl HF, Schmid AM, Mannheim JG, Wiehr S, Lerdkrai C, Calaminus C, Stahlschmidt A et al (2014) Longitudinal PET-MRI reveals beta-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion. Nat Med 20(12):1485\u20131492. doi:\n10.1038\/nm.3734","journal-title":"Nat Med"},{"issue":"2","key":"9218_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57(2):178\u2013201. doi:\n10.1016\/j.neuron.2008.01.003","journal-title":"Neuron"},{"issue":"1","key":"9218_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-014-8694-9","volume":"51","author":"YH Liu","year":"2015","unstructured":"Liu YH, Wang YR, Xiang Y, Zhou HD, Giunta B, Manucat-Tan NB, Tan J, Zhou XF et al (2015) Clearance of amyloid-beta in Alzheimer\u2019s disease: shifting the action site from center to periphery. Mol Neurobiol 51(1):1\u20137. doi:\n10.1007\/s12035-014-8694-9","journal-title":"Mol Neurobiol"},{"issue":"1","key":"9218_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/jad-2011-111418","volume":"28","author":"O Hansson","year":"2012","unstructured":"Hansson O, Stomrud E, Vanmechelen E, Ostling S, Gustafson DR, Zetterberg H, Blennow K, Skoog I (2012) Evaluation of plasma Abeta as predictor of Alzheimer\u2019s disease in older individuals without dementia: a population-based study. J Alzheimer's Dis: JAD 28(1):231\u2013238. doi:\n10.3233\/jad-2011-111418","journal-title":"J Alzheimer's Dis: JAD"},{"key":"9218_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8854-y","author":"YH Liu","year":"2014","unstructured":"Liu YH, Xiang Y, Wang YR, Jiao SS, Wang QH, Bu XL, Zhu C, Yao XQ et al (2014) Association between serum amyloid-beta and renal functions: implications for roles of kidney in amyloid-beta clearance. Mol Neurobiol. doi:\n10.1007\/s12035-014-8854-y","journal-title":"Mol Neurobiol"},{"issue":"3","key":"9218_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/ki.2013.366","volume":"85","author":"UK Seidel","year":"2014","unstructured":"Seidel UK, Gronewold J, Volsek M, Todica O, Kribben A, Bruck H, Hermann DM (2014) The prevalence, severity, and association with HbA1c and fibrinogen of cognitive impairment in chronic kidney disease. Kidney Int 85(3):693\u2013702. doi:\n10.1038\/ki.2013.366","journal-title":"Kidney Int"},{"issue":"23","key":"9218_CR11","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1212\/WNL.0b013e31823b4765","volume":"77","author":"C Helmer","year":"2011","unstructured":"Helmer C, Stengel B, Metzger M, Froissart M, Massy ZA, Tzourio C, Berr C, Dartigues JF (2011) Chronic kidney disease, cognitive decline, and incident dementia: the 3C study. Neurology 77(23):2043\u20132051. doi:\n10.1212\/WNL.0b013e31823b4765","journal-title":"Neurology"},{"issue":"12","key":"9218_CR12","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1212\/wnl.0000000000000251","volume":"82","author":"K Miwa","year":"2014","unstructured":"Miwa K, Tanaka M, Okazaki S, Furukado S, Yagita Y, Sakaguchi M, Mochizuki H, Kitagawa K (2014) Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease. Neurology 82(12):1051\u20131057. doi:\n10.1212\/wnl.0000000000000251","journal-title":"Neurology"},{"issue":"1","key":"9218_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000334742","volume":"35","author":"S Salem","year":"2012","unstructured":"Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, Steppan S, Volsek M et al (2012) Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol 35(1):31\u201339. doi:\n10.1159\/000334742","journal-title":"Am J Nephrol"},{"issue":"2 Suppl 1","key":"9218_CR14","first-page":"S1","volume":"39","author":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","year":"2002","unstructured":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification (2002) Am J Kidney Dis: Official J National Kidney Foundation 39(2 Suppl 1):S1\u2013266","journal-title":"Am J Kidney Dis: Official J National Kidney Foundation"},{"issue":"3","key":"9218_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091176","volume":"9","author":"UK Seidel","year":"2014","unstructured":"Seidel UK, Gronewold J, Volsek M, Todica O, Kribben A, Bruck H, Hermann DM (2014) Physical, cognitive and emotional factors contributing to quality of life, functional health and participation in community dwelling in chronic kidney disease. PLoS One 9(3), e91176. doi:\n10.1371\/journal.pone.0091176","journal-title":"PLoS One"},{"issue":"46","key":"9218_CR16","doi-asserted-by":"publisher","first-page":"42645","DOI":"10.1074\/jbc.M102790200","volume":"276","author":"J Wiltfang","year":"2001","unstructured":"Wiltfang J, Esselmann H, Cupers P, Neumann M, Kretzschmar H, Beyermann M, Schleuder D, Jahn H et al (2001) Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells. J Biol Chem 276(46):42645\u201342657. doi:\n10.1074\/jbc.M102790200","journal-title":"J Biol Chem"},{"issue":"20","key":"9218_CR17","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1002\/elps.200406068","volume":"25","author":"P Lewczuk","year":"2004","unstructured":"Lewczuk P, Esselmann H, Bibl M, Paul S, Svitek J, Miertschischk J, Meyrer R, Smirnov A et al (2004) Electrophoretic separation of amyloid beta peptides in plasma. Electrophoresis 25(20):3336\u20133343. doi:\n10.1002\/elps.200406068","journal-title":"Electrophoresis"},{"issue":"3","key":"9218_CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","volume":"81","author":"J Wiltfang","year":"2002","unstructured":"Wiltfang J, Esselmann H, Bibl M, Smirnov A, Otto M, Paul S, Schmidt B, Klafki HW et al (2002) Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37\/38\/39 in addition to 1-40\/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J Neurochem 81(3):481\u2013496","journal-title":"J Neurochem"},{"issue":"4","key":"9218_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/1073858410391270","volume":"17","author":"A ElAli","year":"2011","unstructured":"ElAli A, Hermann DM (2011) ATP-binding cassette transporters and their roles in protecting the brain. Neuroscientist: Rev J Bringing Neurobiol, Neurol Psychiatry 17(4):423\u2013436. doi:\n10.1177\/1073858410391270","journal-title":"Neuroscientist: Rev J Bringing Neurobiol, Neurol Psychiatry"},{"issue":"3","key":"9218_CR20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00002093-200207000-00009","volume":"16","author":"Z Arvanitakis","year":"2002","unstructured":"Arvanitakis Z, Lucas JA, Younkin LH, Younkin SG, Graff-Radford NR (2002) Serum creatinine levels correlate with plasma amyloid Beta protein. Alzheimer Dis Assoc Disord 16(3):187\u2013190","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"11","key":"9218_CR21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1681\/ASN.2013040330","volume":"24","author":"P Stenvinkel","year":"2013","unstructured":"Stenvinkel P, Zoccali C, Ikizler TA (2013) Obesity in CKD\u2014what should nephrologists know? J Am Soc Nephrol: JASN 24(11):1727\u20131736. doi:\n10.1681\/ASN.2013040330","journal-title":"J Am Soc Nephrol: JASN"},{"issue":"6","key":"9218_CR22","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1084\/jem.20131751","volume":"211","author":"HJ Ahn","year":"2014","unstructured":"Ahn HJ, Glickman JF, Poon KL, Zamolodchikov D, Jno-Charles OC, Norris EH, Strickland S (2014) A novel Abeta-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer\u2019s disease mice. J Exp Med 211(6):1049\u20131062. doi:\n10.1084\/jem.20131751","journal-title":"J Exp Med"},{"issue":"6","key":"9218_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1358\/dnp.2009.22.6.1395256","volume":"22","author":"M Boada","year":"2009","unstructured":"Boada M, Ortiz P, Anaya F, Hernandez I, Munoz J, Nunez L, Olazaran J, Roca I et al (2009) Amyloid-targeted therapeutics in Alzheimer's disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization. Drug News Perspect 22(6):325\u2013339. doi:\n10.1358\/dnp.2009.22.6.1395256","journal-title":"Drug News Perspect"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9218-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9218-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9218-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9218-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:42:20Z","timestamp":1559428940000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9218-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,28]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["9218"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9218-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,28]]}}}